Can pharmacists influence the health-related quality of life of patients with asthma?: The New Zealand pharmaceutical care experience

Sultan Qaboos University Medical Journal

Volumn 3, Issue 2, 2001, Pages 69-75

  Kheir, Nadir ^a   Emmerton, Lynne ^a   Shaw, John ^a  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Asthma; Pharmaceutical care; Pharmacists; Quality of life

Indexed keywords

EID: 0242304328     PISSN: 2075051X     EISSN: 20750528     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lockey RF, DuBuske LM, Friedman B, Petrocella V, Cox F, Rickard K. Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes [In Process Citation]. Chest 1999, 115, 666-73.
2. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J 1996, 9, 636-42.
3. Shaw JP, Emmerton L, Kheir N, Smith N, Clareburt R, Barron P, et al. Otago/Southland Comprehensive Pharmaceutical Care Asthma Project [Final report]. Dunedin: School of Pharmacy, University of Otago, 1999.
4. Hepler CD. Break on through, New Zealand Pharmacy Conference. Pharmacy Today, 1997, 11.
5. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990, 47, 533-43.
6. Fischer LR, Scott LM, Boonstra DM, DeFor TA, Cooper S, Elkema MA, et al. Pharmaceutical care for patients with chronic conditions. J Am Pharm Assoc (Wash) 2000, 40, 174-80.
7. Knoell DL, Pierson JF, Marsh CB, Allen JN, Pathak DS. Meas-urement of outcomes in adults receiving pharmaceutical care in a comprehensive asthma outpatient clinic. Pharmacotherapy 1998, 18, 1365-74.
8. Munroe WP, Kunz K, Dalmady-Israel C, Potter L, Schonfeld WH. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Tier 1997, 19, 113-23.
9. Strand LM, Cipolle RJ, Morley PC. Documenting the clinical pharmacist's activities: back to basics. Drug Intell Clin Pharm 1988, 22, 63-7.
10. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP 1990, 24, 1093-7.
11. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30, 473-83.
12. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992, 47, 76-83.
13. Ware JE, Konsiniski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA, 1994.
14. Hyland ME, Crocker G. Validation of an asthma quality of life diary in a clinical trial. Torax 1995, 50, 724-30.
15. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989, 27, S178-89.
16. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press, 1977.
17. Dyer CA, Hill SL, Stockley RA, Sinclair AJ. Quality of life in elderly subjects with a diagnostic label of asthma from general practice registers. Eur Respir J 1999, 14, 39-45.
18. Bowling A. Measuring disease. Review of Disease Specific Quality of Life Measurement Scales. 2nd ed. Buckingham, Open University Press, 2001.
19. Maille AR, Koning CJ, Zwinderman AH, Willems LN, Dijkman JH, Kaptein AA. The development of the 'Quality-of-life for Respiratory Illness Questionnaire (QOL-RIQ)': a disease-specific quality-of-life questionnaire for patients with mild to moderate chronic non-specific lung disease. Respir Med 1997, 91, 297-309.
20. Muhlhauser I, Richter B, Kraut D, Weske G, Worth H, Berger M. Evaluation of a structured treatment and teaching pro-gramme on asthma. J Intern Med 1991, 230, 157-64.
21. van Grunsven PM, van Schayck CP, van Deuveren M, van Her-waarden CL, Akkermans RP, van Weel C. Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) study. J Asthma 2000, 37, 225-34.
22. Cochrane GM, Horne R, Chanez P. Compliance in asthma. Respir Med 1999, 93, 763-9.
23. Charlton I, Charlton G, Broomfield J, Mullee MA. Evaluation of peak flow and symptoms only self management plans for con-trol of asthma in general practice. BMJ 1990, 301, 1355-9.
24. Jones KP, Mullee MA, Middleton M, Chapman E, Holgate ST. Peak flow based asthma self-management: a randomised controlled study in general practice. British Thoracic Society Research Committee. Thorax 1995, 50, 851-7.
25. Juniper EF, Buist AS, Cox FM, Ferrie PJ, king DR. Validation of a standardised version of the Asthma Quality of Life Question-naire. Chest 1999, 115, 1265-70.
26. Row BH, Oxman AD. Performance of an asthma quality of life questionnaire in an outpatient setting. Am Rev Respir Dis 1993, 148, 675-81.
27. Guyatt GH, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurement properties? J Clin Epidemiol 1992, 45, 1341-5.